Attached files

file filename
EX-10.20 - EX-10.20 - Graphite Bio, Inc.d132211dex1020.htm
EX-10.19 - EX-10.19 - Graphite Bio, Inc.d132211dex1019.htm
EX-10.16 - EX-10.16 - Graphite Bio, Inc.d132211dex1016.htm
EX-10.15 - EX-10.15 - Graphite Bio, Inc.d132211dex1015.htm
EX-10.14 - EX-10.14 - Graphite Bio, Inc.d132211dex1014.htm
EX-10.13 - EX-10.13 - Graphite Bio, Inc.d132211dex1013.htm
EX-10.12 - EX-10.12 - Graphite Bio, Inc.d132211dex1012.htm
EX-10.11 - EX-10.11 - Graphite Bio, Inc.d132211dex1011.htm
EX-10.10 - EX-10.10 - Graphite Bio, Inc.d132211dex1010.htm
EX-10.8 - EX-10.8 - Graphite Bio, Inc.d132211dex108.htm
EX-10.7 - EX-10.7 - Graphite Bio, Inc.d132211dex107.htm
EX-10.6 - EX-10.6 - Graphite Bio, Inc.d132211dex106.htm
EX-10.1 - EX-10.1 - Graphite Bio, Inc.d132211dex101.htm
EX-4.2 - EX-4.2 - Graphite Bio, Inc.d132211dex42.htm
EX-3.3 - EX-3.3 - Graphite Bio, Inc.d132211dex33.htm
EX-3.1 - EX-3.1 - Graphite Bio, Inc.d132211dex31.htm
S-1 - S-1 - Graphite Bio, Inc.d132211ds1.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated April 16, 2021, relating to the financial statements of Graphite Bio, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

San Francisco, California

June 4, 2021